Sofia Pappa

21PUBLICATIONS
49CO-AUTHORS
PharmacogenomicsOther European languagesToxicology (incl. clinical toxicology)Pharmaceutical delivery technologiesClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 08, 2026
A Quantitative Discrete Choice Experiment Survey-Based Study of Preferences for a Hypothetical Long-Acting Injectable Antipsychotic Administered Once Every 2 Months Among People Living with Schizophrenia.

|May 05, 2025
Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in Europe.

Sofia Pappa, Murat Yildirim, Stephanie Loomer

|Mar 02, 2025
Survey on the Initiation of Aripiprazole Once-Monthly via a Two-Injection Start in Adult Patients with Schizophrenia: Experience of European Healthcare Professionals.

Andrea Fagiolini, Karolina Leopold, Sofia Pappa

|Dec 28, 2023
Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study.

Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García

|Sep 18, 2023
Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal.

Juan Antonio García-Carmona, Sofia Pappa

|Jul 19, 2023
Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety.

Joshua Barnett, Sofia Pappa

Pageof 4

Frequent Collaborators

4 joint publications

Paraskevi Katsaounou

3 joint publications

Clodagh Beckham

3 joint publications

Murat Yildirim

2 joint publications

Lindsay H Dewa